We can't find the internet
Attempting to reconnect
18288.1 PFLS-LS
Identification of novel strategies to treat obesity and type 2 diabetes
Zusammenfassung
Identification of novel strategies to treat obesity and type 2 diabetes
Weitere Texte
Abstract
Obesity and its associated co-morbidities such as type 2 diabetes, hypertension and cardiovascular complications have become a major burden worldwide with limited options for treatment. ETH Zürich and Glycemicon continue their successful collaboration on the application of THBA in type 2 diabetes therapy. In the current project both partners will develop a novel biocatalytic routes for production of THBA and elucidate whether THBA could also be employed a type 2 diabetes treatment in pets. Lastly the project aims to uncover new possibilities for the treatment of obesity through the identification of natural products which induce energy expenditure by activating brown fat.
Beteiligte
Nadia Mrosek
Wirtschaftspartner
nmrosek@glycemicon.com
Glycemicon AG Nadia Mrosek Schorenstrasse 16 8603 Schwerzenbach ZH CH
Christian Wolfrum
Kontaktperson
christian-wolfrum@ethz.ch
ETH Zürich Christian Wolfrum Schorenstrasse 16 8603 Schwerzenbach ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2017-12-31
- Bewilligte Gesamtkosten
- CHF 619968.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%